Abstract:Mitochondria play an important and multifaceted role in cellular function, catering to the cell's energy and biosynthetic requirements. They modulate apoptosis while responding to diverse extracellular and intracellular stresses including reactive oxygen species (ROS), nutrient and oxygen scarcity, endoplasmic reticulum stress, and signaling via surface death receptors. Integral components of mitochondria, such as mitochondrial DNA (mtDNA), mitochondrial RNA (mtRNA), Adenosine triphosphate (ATP), cardiolipin, and formyl peptides serve as major damage-associated molecular patterns (DAMPs). These molecules activate multiple innate immune pathways both in the cytosol [such as Retionoic Acid-Inducible Gene-1 (RIG-1) and Cyclic GMP-AMP Synthase (cGAS)] and on the cell surface [including Toll-like receptors (TLRs)]. This activation cascade leads to the release of various cytokines, chemokines, interferons, and other inflammatory molecules and oxidative species. The innate immune pathways further induce chronic inflammation in the tumor microenvironment which either promotes survival and proliferation or promotes epithelial to mesenchymal transition (EMT), metastasis and therapeutic resistance in the cancer cell's. Chronic activation of innate inflammatory pathways in tumors also drives immunosuppressive checkpoint expression in the cancer cells and boosts the influx of immune-suppressive populations like Myeloid-Derived Suppressor Cells (MDSCs) and Regulatory T cells (Tregs) in cancer. Thus, sensing of cellular stress by the mitochondria may lead to enhanced tumor growth. In addition to that, the tumor microenvironment also becomes a source of immunosuppressive cytokines. These cytokines exert a debilitating effect on the functioning of immune effector cells, and thus foster immune tolerance and facilitate immune evasion. Here we describe how alteration of the mitochondrial homeostasis and cellular stress drives innate inflammatory pathways in the tumor microenvironment.

Immunometabolic characteristics of Dendritic Cells and its significant modulation by mitochondria-associated signaling in the tumor microenvironment influence cancer progression

Metabolism of Dendritic Cells in Tumor Microenvironment: for Immunotherapy

Research Progress on Mitochondria Regulating Tumor Immunity.

Mitochondria driven innate immune signaling and inflammation in cancer growth, immune evasion, and therapeutic resistance

Mitochondrial regulation in the tumor microenvironment: targeting mitochondria for immunotherapy

The Role of Metabolic Plasticity of Tumor-Associated Macrophages in Shaping the Tumor Microenvironment Immunity

Metabolic reprograming of MDSCs within tumor microenvironment and targeting for cancer immunotherapy

Effector Functions of Dendritic Cells in Cancer: Role of Cytotoxicity and Growth Inhibition

Tumor-Infiltrating Dendritic Cells: Decisive Roles in Cancer Immunosurveillance, Immunoediting, and Tumor T Cell Tolerance

Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells

Impaired function of dendritic cells within the tumor microenvironment

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients

Modulation of macrophage metabolism as an emerging immunotherapy strategy for cancer

Targeting metabolism to enhance immunotherapy within tumor microenvironment

Dysfunction of dendritic cells in tumor microenvironment and immunotherapy

A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment

Wnt Signaling Cascade in Dendritic Cells and Regulation of Anti-tumor Immunity

Immunometabolic Regulations Mediated by Coinhibitory Receptors and Their Impact on T Cell Immune Responses

Metabolic regulation of the mitochondrial immune checkpoint

Metabolic Reprogramming in Cancer: Implications for Immunosuppressive Microenvironment

Immunometabolism governs dendritic cell and macrophage function